- Home
- IROQ vs PYXS Comparison
IROQ vs PYXS Comparison
Compare IROQ & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IROQ
- PYXS
- Stock Information
- Founded
- IROQ 1883
- PYXS 2018
- Country
- IROQ United States
- PYXS United States
- Employees
- IROQ N/A
- PYXS N/A
- Industry
- IROQ Savings Institutions
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- IROQ Finance
- PYXS Health Care
- Exchange
- IROQ Nasdaq
- PYXS Nasdaq
- Market Cap
- IROQ 75.8M
- PYXS 64.4M
- IPO Year
- IROQ 2011
- PYXS 2021
- Fundamental
- Price
- IROQ $23.96
- PYXS $1.07
- Analyst Decision
- IROQ
- PYXS Strong Buy
- Analyst Count
- IROQ 0
- PYXS 6
- Target Price
- IROQ N/A
- PYXS $9.20
- AVG Volume (30 Days)
- IROQ 1.1K
- PYXS 527.2K
- Earning Date
- IROQ 04-29-2025
- PYXS 05-20-2025
- Dividend Yield
- IROQ 1.66%
- PYXS N/A
- EPS Growth
- IROQ 69.23
- PYXS N/A
- EPS
- IROQ 1.05
- PYXS N/A
- Revenue
- IROQ $25,099,000.00
- PYXS $16,146,000.00
- Revenue This Year
- IROQ N/A
- PYXS N/A
- Revenue Next Year
- IROQ N/A
- PYXS N/A
- P/E Ratio
- IROQ $23.01
- PYXS N/A
- Revenue Growth
- IROQ 12.02
- PYXS N/A
- 52 Week Low
- IROQ $14.85
- PYXS $0.83
- 52 Week High
- IROQ $25.76
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- IROQ 50.35
- PYXS 49.93
- Support Level
- IROQ $23.80
- PYXS $1.05
- Resistance Level
- IROQ $24.46
- PYXS $1.33
- Average True Range (ATR)
- IROQ 0.18
- PYXS 0.10
- MACD
- IROQ 0.03
- PYXS 0.01
- Stochastic Oscillator
- IROQ 58.78
- PYXS 23.53
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.